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Liver TransplantationEthylene Glycol Poisoning Should Not
Contraindicate Liver Donation
Alisha Burman,1 Christopher J. E. Watson, MD, FRCS,2,3 and Vasilis Kosmoliaptsis, PhD, FRCS2,3
Abstract:As the number of patients waiting to receive transplants increases, there is a need to explore all possible donation
opportunities. In this case report, we describe the transplantation of a liver from a donor who died after ethylene glycol poisoning
into a woman with alcoholic liver disease with cirrhosis and associated ascites. Donor management, including ethanol, fomepizol
and haemodialysis, hastened clearance of ethylene glycol from the circulation, and after liver transplantation, the recipient exhibited no
adverse effects suggestive of ethylene glycol toxicity, although recipient hepatic artery dissection and thrombosis necessitated
retransplantation. Our experience suggests that donor death due to ethylene glycol intoxication should not contraindicate liver trans-
plantation, particularly after appropriate donor management.
(Transplantation Direct 2017;3:e212; doi: 10.1097/TXD.0000000000000729. Published online 8 September, 2017.)E thylene glycol (EG) is an odorless, sweet-tasting liquidfound in industrial solutions such as antifreeze and wind-
shieldwiper fluid.Due to its sweet taste, it is sometimes consumed
accidentally by children. Adults tend to ingest it intentionally as a
substitute for alcohol or in an attempt at committing suicide. The
lethal dose of EG is thought to be 1.4 to 1.6 mL/kg1; it exerts
most of its toxicity via its metabolites glycolate and oxalate.
The liver metabolizes approximately 80% of EG (Figure 1),Received 19 May 2017. Revision requested 24 July 2017.
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Transplantation DIRECT ■ 2017and the remaining 20% is excreted unchanged by the kidneys.2
Ethylene glycol exerts its toxicity in 3 stages. In the first
12 hours, its effects are primarily neurological with central
nervous system depression. This is followed by a metabolic
acidosis, with associated cardiopulmonary effects, such as
pulmonary edema and acute congestive cardiac failure. Finally,
after 24 hours, acute renal failure occurs due to calcium oxalate
deposition and metabolic acidosis.3 Oxalate, a metabolite of
EG, binds circulating calcium-forming crystals that deposit in
the renal cortex, causing reduced glomerular filtration. Death
usually occurs during the metabolic acidosis phase, which is
associated with multiorgan failure and cerebral edema, the
latter resulting in brain stem herniation and death.4
In this article, we present a case of transplantation of a
liver from a donor with EG poisoning, and review the rele-
vant literature.CASE DESCRIPTION
The donor liver was recovered from a 26-year-old woman
found collapsed at home after ingesting a bottle of windshield
wiper fluid. She had a history of self-harm and previous EG
overdose attempts. She was intubated upon arrival to the
hospital and given ethanol. Her blood results on admission
included a sodium of 148 mmol/L, potassium of 6 mmol/L,
creatinine of 195 μmol/L (2.2 mg/dL), glucose of 14.9 mmol/L,
aspartate aminotransferase (AST) of 58 iU/L, alanine amino-
transferase (ALT) of 30 iU/L, alkaline phosphatase (ALP) of
209 iU/L, and a total bilirubin of 3 μmol/L (0.18 mg/dL).
On day 2, fomepizole was given instead of ethanol, and she
was started on intermittent hemodialysis. This was stopped
on day 3, because there was no trace of EG or its metabolites
in the blood sample. She was then transferred to intensive
care, where she coned the same day, and brain stem death
was confirmed. The liver was recovered for transplantation
5 days after ingestion of EG.www.transplantationdirect.com 1
FIGURE 1. Metabolismof EGand the possible effect of itsmetabolites.
TABLE 1.
Comparison of reported cases of liver transplantation from donors w
Dy-Liacco Wollf
Donor Age, y 41 4
Sex Male Fe
Blood group
Time from overdose
to brain death
48 h 8
AST, U/I 36 5
ALT, U/I 27 3
GGT, U/I 4
ALP, U/I 48
Total bilirubin, mg/dL 1 0
PT, sec 12.3
Treatment for ingestion
Creatinine, mg/dL
eGFR, mL/min per 1.73 m2
Liver biopsy findings Normal hepatocytes;
no evidence of
inflammation or
crystal deposits
Mild periven
microves
steatosis
periporta
infiltratio
Recipient Age 54 3
Sex Male
Liver injury Alcoholic cirrhosis,
ascites,
encephalopathy
Haemophilia
hepatitis
MELD score at transplant 28 1
Peak postoperative LFTs AST 345
ALT 197 3
ALP 35
Total bilirubin 3.3
PT 23.2
Days until normal LFTs 2
Days until discharge 7 1
Kidney function
postoperative
Serum creatinine, mg/dL
Creatinine (mg/dL) at 6 mo
eGFR at 6 mo
Complications
eGFR, estimated glomerular filtration rate; MELD, Model of End-Stage Liver Disease; LFTs, liver function t
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ALT was 26 iU/L, ALP was 109 iU/L, total bilirubin was
64 μmol/L (3.7 mg/dL), and prothrombin time (PT) at 13 sec-
onds. A liver biopsy before transplantation showed no evidence
of oxalate crystal deposition. The liver was orthotopically
transplanted into a 62-year-old womanwith alcoholic liver cir-
rhosis and ascites. Her Model of End-stage Liver Disease score
was 26 before the transplantation, and her renal function was
normal (creatinine, 42 μmol/L or 0.48 mg/dL). The operation
was complicated by massive hemorrhage, estimated blood loss
of 23 L, and she developed acute kidney injury perioperatively
(peak creatinine, 127 μmol/L or 1.44mg/dL on day 2). Her post-
operative liver function tests on day 7 were ALT of 102 U/L,
ALP of 74 U/L, total bilirubin of 37 μmol/L (2.2 mg/dL),
and PTon day 8 was 12.1 seconds. A computed tomography
scan on day 10 posttransplantation revealed she had an ex-
tensive dissection of the native hepatic artery proximal to
the anastomosis to the donor for which she underwent re-
transplantation on day 22 posttransplant. At that time, she
had recovered normal renal function.ith EG poisoning
McClain Fujji Current case
4 26 31 26
male Male Male Female
B+ O+
d 4 d 5 d 3 d
9 28 32 26
5 7 17 26
9 23 48
52 109
.9 0.5 0.6 3.7
12.1 13
Dialysis until toxicology
is negative
Ethanol, fomepizole,
dialysis until
negative toxicology
5 6.43
8
ous
icular
scarce
l round cell
n; no crystals
No evidence of hepatitis,
centrilobular necrosis,
carcinomas, granulomas
or alcohol induced
injury, no crystals
No evidence
of crystals
2 51 61 62
Male Male Female
A,
C, HIV
Hep C, hepatocellular
carcinoma
ESLD secondary
to nonalcoholic
steatohepatitis
Alcoholic cirrhosis,
ascites
8 22 35 26
1798
75 430 882
39 47
6.7 7.1
25.6
8 9
5 10
3.95 1.44
2
50
AKI that progressed
to chronic kidney
disease
Acute kidney injury;
native hepatic
artery dissection
est; HIV, human immunodeficiency virus AKI; acute kidney injury; ESLD, end stage liver disease.
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There have been 4 previous reports of liver transplantation
from a donor who has died after ingestion of EG. Acute kid-
ney injury is described in just one of the cases.5 Renal failure
in donors is due to metabolic acidosis secondary to glycolate
and calcium oxalate deposition and can occur 24 to 72 hours
after consumption.6One concernwhen accepting the liver from
such a donor is the possibility of EG still being present which
could result in renal failure in the recipient. This seems unlikely
in our case, because after treatment at the donor hospital, there
was no trace of EG in the donor at the time of donation.
After being rapidly absorbed by the gastrointestinal tract,
serum level of EG peaks between 1 and 4 hours postingestion,
and the elimination half-life with preserved renal function is 3
to 8 hours.6 However, ethanol and fomepizole are often given
to prevent the metabolism of EG into its toxic metabolites.
Ethanol is the preferred substrate of alcohol dehydrogenase
and is thus, metabolized in preference to EG, whereas
fomepizole inhibits alcohol dehydrogenase activity, which is
the rate-limiting step in EG metabolism. Because this slows
down the conversion of EG into its metabolites, it changes
the half-life of EG to 19.7 hours.5 This is important to take
into account when working out when EG is fully cleared
and whether the organ is safe to transplant. Hemodialysis of
the donor also reduces the levels of EG and its metabolites. It
should be continued until the blood shows no traces of EG
and its metabolites to prevent acute kidney injury and other
pathologies attributed to EG metabolites in the recipient.
As the number of patients waiting to receive transplants in-
creases, there is a need to explore all possible donation oppor-
tunities. Transplanting the liver from donors who died due to
an EG overdose would appear to be safe, subject to appropri-
ate donormanagement to eliminate EG and its metabolites be-
fore donation. The liver appears to be less susceptible to
oxalate deposits.2 Table 1 updates the table in a previous pub-
lication5 and summarizes all the reported cases to date. In all
cases, liver enzymes were normal before removal of the liver
and the liver biopsies showed no evidence of oxalate crystal
deposits. In addition, Fujii et al2 showed that the allograft
was still functioning 5 years after transplantation. As a result,
so long as the donor is hemodynamically stable, and there areno contraindications to transplanting the liver, it is acceptable
to use livers from donors who died from EG overdose. How-
ever, the recipient should be informed about the liver coming
from an individual who had overdosed and the increased risks
this may pose on them. The adverse result in our case was due
to a dissection of the native hepatic artery extending back into
the celiac trunk and compromising arterial flow into the graft.
It was not related to the cause of donor death.
Although it seems safe to transplant livers, the safety of
transplanting other organs from donors with EG poisoning
is yet to be established. Because the third stage of EG toxicity
involves calcium oxalate crystal deposition often in the renal
cortex, causing acute kidney injury, one must be weary be-
fore using kidneys as allografts.7 However, there have been
reports of successful transplantation of a kidney8 and of a
kidney and pancreas7 in this setting. Because there is a need
for all viable allografts to be used, organs from EGoverdosed
donors should not be dismissed. Rather careful evaluation of
their organs is needed on an individual basis to assess their
suitability, because it is indeed possible to gain successful al-
lograft function.
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